Phenotypical and functional differences in germinative subpopulations derived from normal and psoriatic epidermis.
A model that explains how maintenance of normal homeostasis in human epidermis is achieved describes a heterogeneous cell population of stem cells (SC) and transit amplifying cells (TAC). There must be a tightly regulated balance between SC self-renewal and the generation of TAC that undergo a limited number of divisions before giving rise to postmitotic, terminally differentiated cells. To investigate whether this balance is disturbed in psoriatic epidermis, we have characterized flow sorted enriched SC and TAC using immunocytochemistry, flow cytometry, and real-time quantitative PCR. Our data demonstrate phenotypical and functional differences in SC (beta(1)-integrin bright) and TAC (beta(1)-integrin dim) enriched fractions between normal and psoriatic keratinocytes. Some of these were expected, such as mRNA levels of keratins 6 and 10 and of the Ki-67 antigen. Most remarkable were differences in phenotype of the psoriatic TAC compared with TAC from normal skin. These subpopulations also displayed striking differences following culture. Downregulation of markers associated with the regenerative phenotype (psoriasin, elafin, psoriasis-associated fatty acid binding protein) in cultured psoriatic dim cells in the absence of hyperproliferation suggests that proliferation and regenerative maturation are coupled. From these results, in combination with our earlier findings, we propose a model for epidermal growth control in which TAC play a crucial role.
Franssen
Manon E J
ME
Department of Dermatology, University Medical Centre Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands. m.franssen@derman.umcn.nl
Zeeuwen
Patrick L J M
PL
Vierwinden
Gerty
G
van de Kerkhof
Peter C M
PC
Schalkwijk
Joost
J
van Erp
Piet E J
PE
D015415:Biomarkers; D001706:Biopsy; D002455:Cell Division / Q000502:physiology; D002478:Cells, Cultured; D004817:Epidermis / Q000473:pathology*; D005434:Flow Cytometry; D006801:Humans; D019012:Integrin beta1 / Q000235:genetics; D015603:Keratinocytes / Q000473:pathology* / Q000502:physiology; D019394:Ki-67 Antigen / Q000235:genetics; D010641:Phenotype; D016133:Polymerase Chain Reaction; D011565:Psoriasis / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis
D015415:Biomarkers; D019012:Integrin beta1; D019394:Ki-67 Antigen; D012333:RNA, Messenger